Biohaven Ltd. (BHVN) on Thursday announced the pricing of its underwritten public offering of 5,609,757 shares at $41 per share for gross proceeds of around $230 million.
In addition, Biohaven has granted the underwriters a 30-day option to purchase up to 841,463 shares at the public offering price.
Biohaven intends to use the net proceeds for general corporate purposes.
The offering is expected to be closed on April 22.
J.P. Morgan, Morgan Stanley, TD Cowen, and Piper Sandler & Co. are acting as the joint lead book-running managers of the offering.
BHVN was trading down by 4.43 percent at $42.08 in the pre-market trade on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.